核医学

皇冠hga025大学洛杉矶分校神经内分泌肿瘤项目

找到你的关怀

You can trust 皇冠hga025大学洛杉矶分校健康 to deliver an accurate diagnosis and outstanding care using the latest advances in nuclear medicine. 呼叫 310-794-1005 与专家联系.

寻找供应商
我们的位置

皇冠hga025大学洛杉矶分校神经内分泌肿瘤

We make a difference every day in the lives of patients and their loved ones who are affected by neuroendocrine tumors (NET). The UCLA NET team is dedicated to providing the best possible care from the time that patients are diagnosed throughout their treatment and follow-up period. Our expert physicians and nurses work closely with specialists throughout UCLA to achieve the most successful outcomes.

皇冠hga025大学洛杉矶分校在外科领域有着良好的记录, 医学肿瘤学, 胃肠病学, 内分泌学和影像学. Our faculty includes nationally and internationally renowned experts in the diagnosis and treatment of neuroendocrine tumors. In 2015, the comprehensive resources at UCLA coalesced to form a dedicated Neuroendocrine Tumor Program. The UCLA NET team brings together clinicians in all disciplines involved in taking care of patients with neuroendocrine tumors. 该团队提供世界一流的病人护理, which includes an interdisciplinary tumor board that reviews all patient cases. This joint effort has led to UCLA becoming one of the few expanded access Investigational New Drug trial sites for peptide receptor radionuclide therapy in the U.S.

神经内分泌肿瘤

Neuroendocrine tumors are a heterogeneous group of epithelial neoplasms (abnormal growth of tissue) that originate in hormone-producing cells of the body's neuroendocrine system. 因为神经内分泌细胞几乎存在于身体的每个器官中, net几乎可以出现在任何地方, 包括消化系统, 胰腺和肺.  NETs can show different biological behavior, appearance and response to therapy. Those variances largely depend on their location, hormone production and cell characteristics.

NETs can be grouped by their status as hormone-producing or non-hormone-producing tumors. They can also be classified by their growth rate as well-differentiated or poorly differentiated tumors. Well-differentiated NETs tend to be more biologically indolent (slow to develop) and poorly differentiated NETs — including small cell or large cell neuroendocrine carcinoma — can exhibit more rapid clinical progression. A widely used tool to measure the proliferation rate is Ki-67 (a nuclear protein involved in the cell-cycle regulation). A Ki-67 tumor of less than 3 percent is defined as low-grade (G1); 3 to 20 percent is considered intermediate-grade (G2); and greater than 20 percent is high-grade (G3). Low- and intermediate-grade tumors are considered well-differentiated tumors.

优质护理

我们提供外科专家的诊断和治疗, 医学肿瘤学, 胃肠病学, 病理, radiology and nuclear medicine who are dedicated to treating patients with NETs. 治疗 decisions are based on a discussion for each patient by the tumor board, 考虑到最先进的治疗方法, 创新研究方案和循证医学. We offer patients the most comprehensive care possible to treat NETs by leveraging our world-class programs for pancreas diseases, 肝脏移植手术, 癌症和核医学. 

治疗

Our team is committed to finding the best treatment for each patient. Multiple options are available depending on the type, location and extent of disease. This allows each patient's case to be discussed at our NET tumor board and multidisciplinary meetings. We are the only institution in the region to offer patients comprehensive care, from state-of-the-art PET diagnostics to radiation therapy to 肝脏移植手术ation. 治疗方案包括:

位置

罗纳德·里根皇冠hga025大学洛杉矶分校医疗中心
韦斯特伍德广场757号
洛杉矶，皇冠hga02590095

联系信息

For PRRT information please call Thaiza Adams at (310) 794-7741.

有关UCLA NET团队的问题, including patient issues and information about clinical trials, 请联系劳伦·达马托，电话:(310)206-6889.

韦斯特伍德地图

Click to enlarge Westwood area map >

Other 皇冠hga025大学洛杉矶分校健康 Parking Options >

皇冠hga025 & 视频

Check out the video of the LACNETs Patient Education meeting “Focus on PRRT” on April 14, 2020.

资源 & 链接